$9.36
-0.30-3.11%
At close: -
$9.38
0.020.21%
After Hours: Jun 27, 7:51 PM EDT
Comments
Loading...
BioCryst Pharma Earnings Estimates, EPS & Revenue | NASDAQ:BCRX | Benzinga
BioCryst Pharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Aug 4
EPS Estimate
$0.070
Quarterly Revenue Estimate
$149.53M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$503.49M
Analyze the earnings history of BioCryst Pharma using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| BCRX | BioCryst Pharma | -$0.06 | $0.07 | — | — | $109.33M | $149.53M | — | — | 08/04/2025 | Get Alert |
| BCRX | BioCryst Pharma | -$0.17 | -$0.05 | $0.00 | 100.00% | $92.76M | $127.79M | $145.53M | 13.89% | 05/05/2025 | Get Alert |
| BCRX | BioCryst Pharma | -$0.28 | -$0.06 | -$0.13 | -116.67% | $93.40M | $130.05M | $131.53M | 1.14% | 02/24/2025 | Get Alert |
| BCRX | BioCryst Pharma | -$0.19 | -$0.06 | -$0.07 | -16.67% | $86.74M | $112.50M | $117.08M | 4.08% | 11/04/2024 | Get Alert |
| BCRX | BioCryst Pharma | -$0.24 | -$0.17 | -$0.06 | 64.71% | $82.49M | $98.47M | $109.33M | 11.03% | 08/05/2024 | Get Alert |
| BCRX | BioCryst Pharma | -$0.28 | -$0.21 | -$0.17 | 19.05% | $68.78M | $85.60M | $92.76M | 8.37% | 05/06/2024 | Get Alert |
| BCRX | BioCryst Pharma | -$0.38 | -$0.24 | -$0.28 | -16.67% | $79.55M | $90.01M | $93.40M | 3.77% | 02/26/2024 | Get Alert |
| BCRX | BioCryst Pharma | -$0.23 | -$0.23 | -$0.19 | 17.39% | $75.83M | $85.95M | $86.74M | 0.92% | 11/02/2023 | Get Alert |
| BCRX | BioCryst Pharma | -$0.32 | -$0.25 | -$0.24 | 4.00% | $65.53M | $81.98M | $82.49M | 0.62% | 08/03/2023 | Get Alert |
| BCRX | BioCryst Pharma | -$0.40 | -$0.30 | -$0.28 | 6.67% | $49.92M | $71.68M | $68.78M | -4.05% | 05/03/2023 | Get Alert |
| BCRX | BioCryst Pharma | -$0.40 | -$0.17 | -$0.38 | -123.53% | $47.16M | $75.64M | $79.55M | 5.16% | 02/21/2023 | Get Alert |
| BCRX | BioCryst Pharma | -$0.33 | -$0.28 | -$0.23 | 17.86% | $40.99M | $75.23M | $75.83M | 0.79% | 11/01/2022 | Get Alert |
| BCRX | BioCryst Pharma | -$0.24 | -$0.34 | -$0.32 | 5.88% | $49.96M | $64.31M | $65.53M | 1.90% | 08/04/2022 | Get Alert |
| BCRX | BioCryst Pharma | -$0.36 | -$0.37 | -$0.40 | -8.11% | $19.06M | $51.36M | $49.92M | -2.80% | 05/05/2022 | Get Alert |
| BCRX | BioCryst Pharma | -$0.34 | -$0.30 | -$0.40 | -33.33% | $4.02M | $50.56M | $47.16M | -6.73% | 02/23/2022 | Get Alert |
| BCRX | BioCryst Pharma | -$0.26 | -$0.29 | -$0.33 | -13.79% | $6.10M | $39.38M | $40.99M | 4.10% | 11/03/2021 | Get Alert |
| BCRX | BioCryst Pharma | -$0.24 | -$0.24 | -$0.24 | 0.00% | $2.87M | $28.48M | $49.96M | 75.42% | 08/05/2021 | Get Alert |
| BCRX | BioCryst Pharma | -$0.24 | -$0.27 | -$0.36 | -33.33% | $4.82M | $8.89M | $19.06M | 114.39% | 05/06/2021 | Get Alert |
| BCRX | BioCryst Pharma | -$0.02 | -$0.25 | -$0.34 | -36.00% | $39.73M | $17.52M | $4.02M | -77.08% | 02/25/2021 | Get Alert |
| BCRX | BioCryst Pharma | -$0.34 | -$0.25 | -$0.26 | -4.00% | $1.77M | $3.60M | $6.10M | 69.50% | 11/05/2020 | Get Alert |
| BCRX | BioCryst Pharma | -$0.34 | -$0.25 | -$0.24 | 4.00% | $1.45M | $2.26M | $2.87M | 27.04% | 08/06/2020 | Get Alert |
BioCryst Pharma (BCRX) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q1 | 2025-05-05 | $0 | $-0.05 | 100.0 % |
| Q4 | 2025-02-24 | $-0.13 | $-0.06 | -116.7 % |
| Q3 | 2024-11-04 | $-0.07 | $-0.06 | -16.7 % |
| Q2 | 2024-08-05 | $-0.06 | $-0.17 | 64.7 % |
BioCryst Pharma (BCRX) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q1 | 2025-05-05 | $145.53M | $127.79M | 13.9 % |
| Q4 | 2025-02-24 | $131.53M | $130.05M | 1.14 % |
| Q3 | 2024-11-04 | $117.09M | $112.50M | 4.08 % |
| Q2 | 2024-08-05 | $109.33M | $98.47M | 11.0 % |
FAQ
When is BioCryst Pharma (NASDAQ:BCRX) reporting earnings?
BioCryst Pharma (BCRX) is scheduled to report earnings on August 4, 2025. The last reported earnings were for reported on May 5, 2025 for Q1.
What were the latest earnings per share (EPS) for BioCryst Pharma (NASDAQ:BCRX)?
The Actual EPS was $0.00, which beat the estimate of $-0.05.
What were BioCryst Pharma’s (NASDAQ:BCRX) revenues?
The Actual Revenue was $145.5M, which beat the estimate of $127.8M.
Browse earnings estimates, EPS, and revenue on all stocks.
